Ocular Therapeutix (OCUL): Diabetic Retinopathy Data Q2 2024 And Wet AMD Advancement | Old North State Wealth News
Connect with us

Investing

Ocular Therapeutix (OCUL): Diabetic Retinopathy Data Q2 2024 And Wet AMD Advancement

Published

on

volodyar/iStock via Getty Images

Ocular Therapeutix (NASDAQ:OCUL) has been making extensive progress in being able to advance the use of its Elutyx technology to advance several drug candidates to treat patients with eye disorders. The reason why I think investors may want to

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.